Lobe Sciences Ltd (LOBE.CX)
0.015
0.00 (0.00%)
CAD |
CNSX |
Nov 11, 16:00
Lobe Sciences Enterprise Value: 4.758M for Nov. 11, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 11, 2024 | 4.758M |
November 08, 2024 | 4.758M |
November 07, 2024 | 4.758M |
November 06, 2024 | 4.758M |
November 05, 2024 | 4.758M |
November 04, 2024 | 4.758M |
November 01, 2024 | 5.616M |
October 31, 2024 | 5.616M |
October 30, 2024 | 5.616M |
October 29, 2024 | 5.616M |
October 28, 2024 | 5.616M |
October 25, 2024 | 5.616M |
October 24, 2024 | 5.616M |
October 23, 2024 | 5.616M |
October 22, 2024 | 5.616M |
October 21, 2024 | 5.616M |
October 18, 2024 | 4.758M |
October 17, 2024 | 4.758M |
October 16, 2024 | 5.616M |
October 15, 2024 | 5.616M |
October 11, 2024 | 5.616M |
October 10, 2024 | 5.616M |
October 09, 2024 | 5.616M |
October 08, 2024 | 5.616M |
October 07, 2024 | 4.758M |
Date | Value |
---|---|
October 04, 2024 | 4.758M |
October 03, 2024 | 4.758M |
October 02, 2024 | 5.616M |
October 01, 2024 | 5.616M |
September 30, 2024 | 5.616M |
September 27, 2024 | 4.758M |
September 26, 2024 | 5.616M |
September 25, 2024 | 5.616M |
September 24, 2024 | 5.616M |
September 23, 2024 | 5.616M |
September 20, 2024 | 5.616M |
September 19, 2024 | 5.616M |
September 18, 2024 | 5.616M |
September 17, 2024 | 5.616M |
September 16, 2024 | 5.616M |
September 13, 2024 | 5.616M |
September 12, 2024 | 5.616M |
September 11, 2024 | 5.616M |
September 10, 2024 | 5.616M |
September 09, 2024 | 5.616M |
September 06, 2024 | 5.616M |
September 05, 2024 | 5.616M |
September 04, 2024 | 5.616M |
September 03, 2024 | 5.616M |
August 30, 2024 | 5.616M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-1.810M
Minimum
Jan 24 2022
44.52M
Maximum
Feb 22 2021
6.139M
Average
3.918M
Median
Jun 05 2023
Enterprise Value Benchmarks
Biocure Technology Inc | 0.4866M |
Core One Labs Inc | -- |
Restart Life Sciences Corp | 1.234M |
Nanosphere Health Sciences Inc | 0.3707M |
Algernon Pharmaceuticals Inc | -- |
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.4268M |
Total Expenses (Quarterly) | 0.6236M |
EPS Diluted (Quarterly) | -0.0027 |
Earnings Yield | -267.2% |
Normalized Earnings Yield | -266.26 |